Welcome to the latest issue of EMJ Nephrology! We are excited to share with you a collection of the latest nephrology insights, including peer-reviewed research alongside a review of the European Renal Association – European Dialysis and Transplant Association (ERA–EDTA) Congress 2021 with hot-topic news straight from the virtual event and summaries of some of the abstracts presented.
EMJ Nephrology 9.1 2021
Latest articlesAll articles
Ocedurenone: A Novel Therapy for Uncontrolled Hypertension in Advanced Chronic Kidney Disease
Setting the scene, Bakris defined CKD as a reduction in kidney function (estimated glomerular filtration rate [eGFR] <60 mL/min/1.73 m2), alongside the presence of albuminuria (≥30 mg/day) as an indication of kidney damage.
Editor's Pick: Metabolic Acidosis in Children: A Literature Review
Metabolic acidosis is characterised by a primary decrease in the serum bicarbonate concentration, a secondary decrease in the arterial partial pressure of CO2, and a reduction in blood pH. Metabolic acidosis, acute or chronic, may have deleterious effects on cellular function and cause increased morbidity and mortality.
Hypertension in Patients Receiving Dialysis: A Review of the Current Clinical Approach
Hypertension is a common complication in advanced chronic kidney disease (CKD), occurring in approximately 80–85% of patients. Blood pressure (BP) control is suboptimal in the majority of these patients. The link between uncontrolled hypertension and mortality among patients with end-stage kidney disease (ESKD) is well documented.
Prevalence of SARS-CoV-2 Cellular and Humoral Immunity Amongst Patients on Dialysis After the First Vaccination Campaign
Global immunisation against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the standard-of-care in preventing COVID-19 and, in the absence of a specific antiviral therapy, the only effective action against this pandemic.